Toggle3D.ai CEO Evan Gappelberg Buys 15,000 Shares of Company Stock In Open Market Purchases

Toggle3D.ai (the "Company") (CSE:TGGL)(OTCQB:TGGLF), a revolutionary SaaS solution harnessing the power of generative AI to convert CAD files, apply stunning 4K texturing, and seamlessly publish superior 4K 3D models, announces that the CEO Evan Gappelberg has purchased 15,000 shares in open market buys on August 24th & 25th with an avg purchase price of $0.54 USD or $0.75 CAD

Evan Gappelberg CEO of Toggle3D.ai Comments "Toggle3D.ai went public in June and hit a high of $4.75 CAD…today however I'm now able to buy at $.45 USD or about $.61 CAD and we have more subscribers. To me, our share price is very low and not reflective of the upside potential that I see with our generative AI texturing platform, which is seeing rapid growth of its user base and early success." He continues "I'm investing today because I see many years of strong forward growth ahead for our businesses."

Recent Toggle3D.ai News

Toggle3D.ai Approved and Now Trading on the OTCQB Exchange Under the Ticker TGGLF
Toggle3D.ai Integrates With Sketchfab Offering New Unlimited AI-Generated 3D Model Texturing Options & One-Click Account Access
Toggle3D.ai Launches Exclusive AI-Powered Material Creation Template as a Paid For Monthly Subscription

About Toggle3D.ai

Toggle3D.ai (CSE:TGGL) (OTCQB:TGGLF) is a groundbreaking SaaS solution that utilizes generative AI to convert CAD files, apply stunning 4K texturing, and enable seamless publishing of superior 4K 3D models, serving various industries within the $160 billion CGI market. With its Augmented Reality-based rapid prototyping web app, Toggle3D empowers designers, artists, marketers, and eCommerce owners to effortlessly convert, texture, customize, and publish high-quality 3D models and experiences, regardless of technical or 3D design expertise.

Toggle3D.ai Investor Relations

Visit the Toggle3D Investor Relations website and sign up for the investor mailing list to receive the latest news, press releases, investor presentations, CEO interviews, financial information and more.

Sign up for the investor mailing list - click here

Follow Toggle3D.ai on Social Media
Youtube: https://www.youtube.com/@Toggle3D
Insta: https://www.instagram.com/Toggle3D.ai/
Facebook: https://www.facebook.com/Toggle3D
LinkedIn: https://www.linkedin.com/company/toggle3d-ai/
Twitter: https://twitter.com/Toggle3Dai

For further information, please contact:

Investor Relations Contact(s)
Julia Viola, Lindsay Betts
investor.relations@toggle3D.ai

Toggle3D.ai

Evan Gappelberg
CEO and Director
866-ARITIZE (274-8493)

Forward-looking Statements

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Certain information contained herein may constitute "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as, "will be" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements regarding the completion of the transaction are subject to known and unknown risks, uncertainties and other factors. There can be no assurance that such statements will prove to be accurate, as future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Nextech will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

SOURCE:Toggle3D.ai Inc.

View source version on accesswire.com:
https://www.accesswire.com/777839/Toggle3Dai-CEO-Evan-Gappelberg-Buys-15000-Shares-of-Company-Stock-In-Open-Market-Purchases

News Provided by ACCESSWIRE via QuoteMedia

cse:tggl artificial intelligence stocks cse stocks emerging tech investing Emerging Tech Investing

TGGL:CC

Toggle3D.ai's AI Lab Announces Breakthrough With Generative AI Photo Rendering

Toggle3D.ai (the "Company") (CSE:TGGL)(OTCQB:TGGLF), a revolutionary SaaS solution harnessing the power of generative AI to convert CAD files, apply stunning 4K texturing, and seamlessly publish superior 4K 3D models, is delighted to announce a breakthrough in its Artificial Intelligence (AI) lab for generative AI photo rendering. This AI tool is expected to drive significant revenue as it is being offered exclusively as part of the Toggle Pro Paid Subscription plan

With the generative AI photo rendering feature, when users upload a 3D model, regardless of whether it's pre-textured or not, the AI rendering tool can quickly create high-quality 2D images of different texture design ideas for the users' 3D model. It puts the 3D object in a 2D scene and textures it according to the prompt provided by the user. The purpose of these 2D images is to provide users with a quick way of prototyping and visualizing how their 3D model could look in different textures, styles and materials. This feature is especially useful for industry designers in manufacturing sectors who are prototyping designs for their products, such as furniture, automotive, machinery etc.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Syntheia Enhances Inbound Customer Calls with AI-Powered Virtual Assistants, Positively Impacts Sales and Customer Satisfaction

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is transforming customer service by delivering an innovative solution that uses natural language processing (NLP) to handle inbound telephone calls with virtual assistants. Since its beta launch in June 2023, Syntheia has processed over 750,000 conversations, bringing new levels of efficiency and engagement to businesses in diverse industries.

Companies like Georgetown Hyundai, Palmieri Furniture, Campio Furniture, and Pay N Go have all embraced Syntheia's platform, highlighting its positive impact on sales and customer satisfaction.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Zero Candida Technologies Inc. Opens the Market

Eli Ben-Haroosh, Co-Founder and Chief Executive Officer, Zero Candida Technologies Inc. (TSXV: ZCT) ("Zero Candida" or the "Company"), joined Dani Lipkin, Managing Director, Global Innovation Sector, Toronto Stock Exchange, to open the market to celebrate the Company's new listing on the TSX Venture Exchange.

Zero Candida Technologies, Inc. (ZCT), is a medical device company bringing female healthcare into the 21st century. They are transforming the treatment of Vulvo-Vaginal Candidiasis ("VVC"), which affects 75% of women worldwide, often recurrent and increasingly drug-resistant with current treatments failing to address the root cause effectively. Free from chemicals and side effects, their AI-driven tampon-like device enables real-time data collection and transmission to physicians for personalized, at-home treatment. Beyond VVC, ZCT aims to revolutionize gynecology, improving access for underserved populations and advancing hybrid medicine.

Please refer to the Company's website here.

MEDIA CONTACT:
Victoria Gamble
Corporate Development Consultant
victoria@zero-candida.com
416-706-0332

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/231280

News Provided by Newsfile via QuoteMedia

Keep reading...Show less

Toggle3D.ai CEO Evan Gappelberg Buys 15,000 Shares of Company Stock In Open Market Purchases

Latest News

Latest Press Releases

Related News

TOP STOCKS